by Dr. C.H. Weaver M.D. updated 5/2020
Although the majority of skin cancers fall under basal cell and squamous cell carcinomas (number of cases estimated to be around 5 million), most deaths are a result of melanoma which accounts for approximately 1% of cases.
In 2019, the ACS estimates 80,000 new individuals will be diagnosed and 10,130 deaths will be related to melanoma. As the month of May comes into focus, it’s time to increase public awareness of skin cancer, including its prevalence, screening and prevention, treatment options, and resources that offer updated information on this disease throughout the year.
- Overview of Melanoma
- Skin Examinations Remain Best Approach for Early Detection
- How to Recognize Melanoma & Do a Skin Examination
- Keytruda is New Standard for Stage III Melanoma
- Targeting BRAF & MEK
- Did you know Melanoma is more common in cancer survivors?
For individuals and loved ones of individuals going through a new diagnosis or treatment for Melanoma, the CancerConnect community is available to discuss issues and questions related to this disease, or just for general support. Connect with others being treated at the best cancer centers. You can sign up privately for melanoma here.
Two Year TKI Consolidation Allowed for TKI Cessation in Select Patients With CML
Research suggests some patients with CML can safely discontinue TKI therapy - NCCN guidelines published.